Child with bleeding problems Dr Neoh Hui Pheng Hospital Seberang Jaya
Dec 17, 2014
Child with bleeding problems
Dr Neoh Hui Pheng Hospital Seberang Jaya
Normal Hemostasis
Def : consequence of tightly regulated processes that maintain blood in a fluid, clot-free state in normal vessels while introducing the rapid formation of a localized hemostatic plug at the site of vascular injury.
Mechanism vasocontriction formation of platelet plug coagulation cascade fibrinolysis
The coagulation cascade
Classification of bleeding disorder
Coagulation Vs Platelet defects
Comparing coagulation factor and platelet defects
Coagulation factor defects Platelet disorders and von Willebrand's disease
Bruising on trunk and limbs Large bruises Small bruises
Bleeding from cuts Relatively slight Profuse
Nosebleeds Uncommon Common, frequently profuse and of long duration
Gastrointestinal bleeding Uncommon Common
Haematuria Common Rare
Haemarthrosis In severe haemophilia Very rare
Bleeding after surgery or dental extraction
Up to a day's delay before bleeding occurs Immediate bleeding
Hemophilia
Hemophilia
Defect in clotting mechanism Hemophilia A : Deficiency of Factor
VIII ( 85%) Hemophilia B : Deficiency of Factor IX ( 15%)
70 % X linked recessive. 30 % spontaneous mutation with no family hx.
Presentation:
Rarely,bleeding symptoms may present from birth ( Factor 8 and 9 do not cross placenta)
- Intracranial hemorrhage /prolonged oozing from heel stick/venepuncture sites.
- Most children present with easy bruising when crawling and walking ( ard 9-12 months)
- Hemarthrosis – characteristic. - large joints ( ankle, knee, elbow ) – swollen
and painful ( ankle joint : often the earliest joint involved. )
Presentations
Other bleeding tendencies: Epitaxis, gum bleeding , hematuria.
Bleeding can be spontaneously, after trauma , operation or dental procedures.
Lungs/ CVS / PA : unremarkable
Investigations
FBC Coagulation screen : PT/ APTT RP / LFT Specific factor assay : Factor 8 or factor 9 Von willebrand screen even if APTT
normal .Others : - Infective screen ( at diagnosis and yearly) :
Hep B/ Hep C /HIV - Platelet aggregation if highly suspicious of
platelet defect.
Classification
Classification Clinical manifestation
Severe(<1% of normal)
•Manifest in infancy when child reaches toddler stage• Spontaneous bleeding – in muscles or joints (haemarthroses)• Excessive bleeding after minor trauma, postoperatively, or after intramuscular childhood vaccinations
Moderate( 1-5% of normal)
•Manifest after 2 years of life• Moderate trauma causes bleeding episodes• Occasionally spontaneous bleeding occurs
Mild ( >5 % - < 40% of normal)
• Often diagnosed in teenagers and adults• Significant trauma/surgery or dental procedures to induce bleeding• No spontaneous bleeding
Management
First Aid ( PRICE) : Pressure, Rest, Ice, Elevation
Factor VIII /IX replacement Infuse factor 8 by slow IV push at the rate not
exceeding 100U/ min in young children. FFP and cryoprecipitate should not be
used as there is higher risk of viral transmission.
Management
Type of bleed Factor VIII dose Factor IX dose
Hemarthrosis 20U/kg 40 U /kg
Soft tissue or muscle bleeds
30-40U/kg 60-80 U /kg
Intracranial hemorrhage or Surgery
50U /kg 100 U /kg
Management ( contd)
Calculate the required dose:- Factor VIII : ( % rise reqd) x ( wt in
kg) x 0.5- Factor IX : (% rise reqd) x ( wt in kg)
x 1.4Type of bleed % rise required
duration
Haemarthroses 30-40% 2-3 days
Soft tissue /Muscle bleed( Risk of compression/compartment syndrome)
40-50% 4-5 days
Intracranial bleed /operation
100% 7-10days
management
Analgesic often not required ( as there is rapid pain relief after missing factor concentrate is infused)
- AVOID I.M injection - Don’t use Aspirin/NSAIDs – affect
platelet fx - Acetaminophen with or without
opioids can provide adequate pain control
management
Dental care is required as dental caries are a regular source of bleeding.
In severe cases, dental clearance with factor replacement will be required.
Medic alert bracelet Register with hemophilia society.
Complications
1) Joint destruction : Recurrent hemarthrosis into the same joint osteoarthritis and joint deformity.
Preventable by prompt and adequate factor 8 replacement.
2) Infection : Hep B/Hep C and HIV - All hemophiliacs must be immunised
with Hep B
Complications
3) Inhibitors: Antibodies directed against the exogeneous Factor VIII and IX neutralising the clotting activity.
Can develop at ANY age, but usually 10-20 exposure days.
Suspected when there is lack of response to replacement therapy instead of higher doses.
2 agents – “bypassing” the deficient clotting factor : i) Recombinant activated Factor VII ( rfVII or
Novoseven) ii) FEIBA ( Factor Eight Inhibitor Bypass Activity) Immune tolerance induction Refer to hematologist in specialised centres.
Immune thrombocytopenic purpura ( ITP)
Thrombocytopenia
neonatal alloimmune thrombocytopenia- Thrombocytopenia in < 6 months Sepsis and infections ( eg HIV ) Drug induced thrombocytopenia Hematological Malignancy -eg : Acute leukemia Congenital marrow failure syndromes -eg : Fanconi anemia , thrombocytopenia with absent radius Autoimmune disorders- Eg : SLE , Evan syndrome Primary immunodeficiency syndromes- Wiskott-aldrich syndrome
Immune thrombocytopenic purpura
ITP
Isolated thrombocytopenia with NORMAL blood counts in a patient, with no clinically apparent alternative cause of thrombocytopenia .
In children, ITP is an acute but self limiting that resolves spontaneously.
Autoantibodies bind to platelet membrane antigen
Increased platelet destruction Subtypes : 1) Acute ITP
2) Chronic ITP
Presentations
Usually acute onset. Majority will have h/o viral
infection in the preceding 2-4 weeks.
Can be present as mild cutaneous bleed like petechiae , to mucosal bleeds like gum bleeding or epitaxis , to life threathening bleeds like Intracranial hemorrhage.
Diagnosis
Based on history, examination and investigation.
Physical examination : Absence of hepatosplenomegaly or lymphadenopathy.
FBC : Isolated low platelet, normal Hb and TWBC
FBP : Normal, apart from reduced larger platelet, no abnormal cells.
Coagulation profile : prolonged BT, normal PT and APTT.
When to do BMA ?
Usually not require BMA, unless child present with Atypical features ( eg : Organomegaly, significant lymphadenopathy, abnormal blood counts or suspicious FBP. )
Before starting steroid therapy ( to avoid partially inducing an undiagnosed acute leukemia)
If there is failure to respond to Immunoglobulin therapy
When there is persistent thrombocytopenia more than 6 months.
Thrombocytopenia recurs after initial response to treatment.
Atypical presentations
Antinuclear factor and DNA antibodies
Coomb’s test CMV serology ( < 1 yr old ) Coagulation profile ( suspected NAI
and inherited bleeding disorder) HIV testing for those at risk ( eg
parents RVD + or IVDU ) Immunoglobulin factor for those with
recurrent infection
Management( treat the child, not the platelet count )
Most children remit spontaneously - 70% achieve platelet count > 50x 109/L by the
end of 3rd week. Careful observation with monitoring of platelet
count , without specific treatment is appropriate for patient with :
- Platelet count > 20x 109/L without bleeding - Platelet count > 30x 109/L with only cutaneous
purpura- repeat FBC within 7-10 days to ensure there is
no evidence of serious evolving marrow condition.
Advise precautions with physical activities , avoidance of contact sports and seeking immediate medical attention if bleeding occurs should be advised.
When to hospitalise?
Hospitalise the child if - Severe life threathening bleding eg
ICH regardless of platelet count - Platelet count < 20x 109/L with
evidence of bleeding - Platelet count < 20x 109/L without
bleeding but inaccessible to health care. - Parents request due to lack of confidence
in home care.
Management ( contd)
Treatment indicated if - Life threathening bleeding like ICH- Platelet count < 20x 109/L with
mucosal bleeding - Platelet count < 10x 109/L with any
bleedingChoices of treatment: i) Oral prednisolone 2mg/kg/day for
14 days then taper offii) Oral prednisolone 4mg/kg/day for 4
daysiii) IVIG 0.8mg/kg/dose for a single
dose.
Management
Note that the above mentioned regimes do not help to reduce bleeding complications or mortality or influence progression to chronic ITP.
S/E of IVIG ( 15-75%) : - fever, flushing, headache, nausea, aseptic
meningitis, transmission of Hep C ( older preparation )
Steroid should not be continued if there is no response or if there is a rapid relapse after withdrawal.
Treatment should not be directed at increasing the platelet count above a preset level but rather on the clinical status of the patient.
Chronic ITP
Persistent thrombocytopenia after 6 months of onset ( in 20% )
Wide spectrum of manifestation: - Mild asymptomatic low platelet
count -> intermittent relapsing symptomatic thrombocytopenia -> rare stubborn and persistent symptomatic and hemorrhagic disease.
Acute Vs Chronic ITP
Feature Acute ITP Chronic ITP
Peak age Children (2-6 yrs) Adults (20-40 yrs)
Female:male 1:1 3:1
Antecedent Infection Common Rare
Onset of symptoms Abrupt Insidious
Platelet count at presentation
<20 000 <50 000
Duration 2-6 weeks Long term
Spontaneous remission
Common Uncommon
management
Try to give enough time for the disease to remit spontaneously.
EXCLUDE other causes of thrombocytopenia. Asymptomatic child – Observe and conservative +
precaution in physical activity Symptomatic- short course of treatment like acute
ITP Counselling to parents- natural history of disease
and detecting symptoms and complications. Parents should be confident in taking care of child
with persistent low platelet count at home. Must know when and how to seek early medical
attention.
2nd line therapy?
For child with persistent bleeding. MUST d/w paediatric hematologist before
initiating. Pulses of steroid : - Oral dexamethasone 1mg/kg given on 4
consecutive days every 4 weeks for 4 months.
Intermittent anti-RhD Immunoglobulin treatment for Rh +ve : 45-50mcg/kg – May cause drop in Hb level.
Splenectomy is rarely indicated.
Platelet count
PT APTT Bleeding time
Thrombin time
Additional test
Hemophilia A
N N Prolonged
N Factor 8 low
Hemophilia B
N N Prolonged
N Factor 9 low
Von Willebrand’s disease
N N Prolonged or Normal
N VWF / Factor 8 low- Impaired ristocetin impaired platelet aggregation
Liver disease
Low Prolonged
prolonged
N (Rarely prolonged)
DIC Low Prolonged
prolonged
Grossly prolonged
Oral anticoagulant
N Grossly Prolonged
Prolonged
N
Heparin Normal( rarely low)
Mildly Prolonged
Prolonged
Prolonged
Case
April 2013 10 yrs old , Chinese , boy, BW : 30kgp/w : 1) pain, swelling and reduced movement for
both elbows X 2/7 2) Bruises over bilateral knee
Denies history of recent contact sports. Denies history of trauma Denies history of fall. No other bleeding tendency like epitaxis, gum
bleeding, hemetemesis, hemoptysis, hematuria, malena, petechiae or bruises at other body part.
He has had multiple previous admissions since young for joint swellings or soft tissue injury like calf swelling and bruises.
Child was previously followed up in Hospital Sultanah Aminah since 1 yr old of age.
Blood investigation during 1 yr old: - PT 11.9 - APTT 106.6 - Factor VIII <1.0% - Von Willebrand factor 103.1%
What do you think ?
Past history
He was diagnosed with Hemophilia A since 1 yr old. In 2012, he was referred to HSJ for follow up due to
logistic reason . May 2012 : right thigh swelling after a fall- Factor VIII 750U ( 30U/kg ) x 3 doses August 2012:right elbow swelling and bruises after
falling down in basketball court.- Factor VIII 750U x 15 doses September 2012 : bilateral knee bruises after
playing with a friend. - Factor VIII 750 U x 7 doses November 2012: Swelling over elbow . Admitted to
HSAH in SP. Factor VIII given, child was not admitted.
Development history: standard 4 student with average performance. ( frequent absence from school due to frequent admissions)
Family & Social history:Father is single parent. Mother is
cambodian, was told to be carrier of hemophilia. Parents already divorced. He is the only son.
o/e : Alert, pink , active and comfortable. Not dyspneic, not tachypneic. Good perfusion , good pulse volume, CRT < 2 secs. No petechiae over body. No gum bleeding/nose
bleeding.Lungs : A/E equal, clearCVS : DRNM PA : soft, not distended, no liver / spleen palpable.Local findings :both elbows slightly swollen and warm
on touch. Restricted ROM : 75-135 degrees bilaterally. Bruises over both knees. However, bilateral knee has
full ROM.
Ix : - FBC : Hb 12.8 , TWC 8.4 , Plt 414 - PT 12.6, APTT 85.5 , INR 1.0Management:- Given Factor VIII 750 U BD ( 25mg/kg/dose)
for 2 days, followed by 750U OD for 3 days. A total of 7 doses given.
- Subsequently, child had full ROM in right elbow, however, his left elbow still slightly restricted to 15-145 degrees.
TCA stat if hemarthrosis/ soft tissue bleeding / bleeding tendency.
Advise child not to take part in contact sports.
Thank you !